Nmwj. De Bruin et al., Hippocampal and cortical sensory gating in rats: Effects of quinpirole microinjections in nucleus accumbens core and shell, NEUROSCIENC, 105(1), 2001, pp. 169-180
Sensory processing disturbances, as measured in the P50/sensory gating para
digm, have been linked to aberrant auditory information processing and sens
ory overload in schizophrenic patients. In this paradigm, the response to t
he second of paired-click stimuli is attenuated by an inhibitory effect of
the first stimulus. Sensory gating has been observed in most healthy human
subjects and normal laboratory rats. Because mesolimbic dopamine has been i
mplicated in other filtering disturbances such as prepulse inhibition of th
e acoustic startle response and given the fact that amphetamine and apomorp
hine have been shown to disrupt gating, this study was performed to investi
gate the role of mesolimbic dopamine in sensory gating. The dopamine D2 rec
eptor agonist quinpirole (10 mug/0.5 mul) was injected bilaterally in nucle
us accumbens core and shell and effects on cortical and hippocampal sensory
gating were investigated. Also, effects of the dopamine D2 receptor antago
nist haloperidol (0.1 mg/kg, subcutaneously) as pretreatment were studied.
First, quinpirole significantly reduced both the amplitude to the first cli
ck and gating as measured in the cortex and in the hippocampus. There was a
tendency for the quinpirole effects on hippocampal gating to be more prono
unced in rats injected in the shell. Secondly, haloperidol did not antagoni
ze effects of quinpirole on hippocampal parameters, whereas haloperidol pre
treatment fully antagonized quinpirole effects on cortical parameters.
In conclusion, gating can be significantly reduced when a dopamine agonist
is specifically targeted at mesolimbic dopamine D2 receptors. However, an i
mportant consideration is that the dopaminergic effects in the present stud
y on gating are predominantly mediated by the effects on the amplitude to t
he first click. This has also been suggested for systemic amphetamine injec
tions in rats and schizophrenic patients. This casts doubt on whether dopam
ine receptor activation affects the putative inhibitory process between the
first and the second stimulus. (C) 2001 IBRO. Published by Elsevier Scienc
e Ltd. All rights reserved.